Neurological DisorderNCT05425186
A Reliability and Validity Study: Urdu Version of Rivermead Extended Activities of Daily Life
An observational study of Neurological Disorder, run by Riphah International University at 1 site in Pakistan.
Trial summary
The goal of this study is to translate and culturally adapt Rivermead Extended Activities of Daily Life into the Urdu language and to evaluate its reliability and validity in the Pakistani neurological rehabilitation population. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Neurological Disorder
- How many people
- 100 participants
- Where
- 1 sitePakistan
- Study dates
- 30 May 2021to 12 Jul 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: We targeted the Pakistani stroke and head injury population received rehabilitation for neurological impairments in our study.
Who may be able to join
- Patients from Rehabilitation centers mainly outpatients; with more or severe impairments due to neurological /neuro-muscular diseases.
- Patient should be in a stable state unlikely to change over 2- weeks.
- Patient should score 18/28 short orientation-memory-concentration test; indicating a reasonable cognitive and communicative ability.
Who cannot join
- People not suffering from any neurological impairment.
- Scorning less than 18/28 on short orientation-memory-concentration test.
Trial locations and contacts
1 site in 1 country.
Pakistan1 site, 1 recruiting
- Recruiting
Ripah International University
Faisalabad, Punjab Province, 38000
Muhammad Kashif, 0418777210, kashif.shaffi@gmail.com
About this study
Official title: Analysis of Reliability and Validity of Urdu Version of Rivermead Extended Activities of Daily Life Among Pakistani Population
The goal of this study is to translate and culturally adapt Rivermead Extended Activities of Daily Life into the Urdu language and to evaluate its reliability and validity in the Pakistani neurological rehabilitation population. Also assess its correlation with Memory and Concentration Test, The Barthel Index, and The index of French activities.
Read the detailed description
As per the preceding commendation, Rivermead Extended Activities of Daily Life will be deciphered into the Urdu dialect from its English adaptation and adjusted socially in Pakistan. Among the neurological rehabilitation population, Rivermead Extended Activities of Daily Life will be distributed in 100 patients enrolled by comfort inspecting strategy beneath the pre-defined incorporation and avoidance criteria after marking assent shapes. For testing inter-observer unwavering quality and intra-observer unwavering quality of Rivermead Extended Activities of Daily Life, Memory and Concentration Test, index of French activities, and Barthel Index surveys will be managed by spectator, on the same day, with a time interval of 2 hours between 1st and 2nd readings. As for the 3rd readings, it will be carried out after seven days by the first observer, for intra-observer appraisal. Statistical Package of Social Sciences computer program has been utilized for information passage and examination. Inner consistency will be analyzed with Cronbach alpha esteem. Test-retest unwavering quality will be surveyed by utilizing an intra-class relationship coefficient. The Rivermead Extended Activities of Daily Life will be assessed for content validity, construct validity, criterion validity, and responsiveness.
- Conditions
- Neurological Disorder
- Keywords
- Rivermead Extended Activities of Daily Life, Urdu Version, Reliability, Validity, Neurological Disorder
- Medical subject headings
- Nervous System Diseases
What is being measured
The primary outcome is the main question the study is designed to answer.
Rivermead Extended Activities of Daily Life
Rivermead Extended Activities of Daily Life having 10 things in it is in fact could be a complete independent community survival scale, covering all the fundamental independent living fashion needs. Restoration administrations are pointed at accomplishing social autonomy within the community, on the off chance that conceivable, and must utilize an fitting degree of Rivermead Extended Activities of Daily Life when they are assessed themselves.
Measured: 1st day
Memory and Concentration Test
The Brief Introduction Memory and Concentration Test is one of numerous tests of memory and concentration. It has the advantage of having decently culture-free substance. In expansion, it covers moderately restricted zones of cognition: is the individual arranged; can the individual center on a brief errand; and can the person learn and keep in mind a number of basic things.
Measured: 1st day
Frenchay Activities Index
The Frenchay Activities Index is a measure of instrumental activities of daily living for use with patients recovering from stroke.
Measured: 1st day
Barthel Index
The Barthel index is used to assess disability and to monitor changes in disability over time. The scoring method takes into account whether the person evaluated receives help while doing each task.
Measured: 1st day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Jun 2022
- Study start30 May 2021
- Primary completion10 Jul 2022 (estimated)
- Study completion12 Jul 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Neurological DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Muhammad Kashif, Study chair, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05425186
- Sponsor's protocol ID
- REC-FSD-00263
- Status last verified
- Jun 2022
- First submitted
- 15 Jun 2022
- Last updated
- 21 Jun 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Jun 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Analysis of Reliability and Validity of Urdu Version of Rivermead Extended Activities of Daily Life Among Pakistani Population
- ClinicalTrials.gov ID
- NCT05425186
- Acronym / sponsor ID
- REC-FSD-00263
- Conditions
- Neurological Disorder
- Keywords
- Rivermead Extended Activities of Daily Life, Urdu Version, Reliability, Validity, Neurological Disorder
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 30 May 2021 (actual)
- Primary completion
- 10 Jul 2022 (estimated)
- Study completion
- 12 Jul 2022 (estimated)
- First posted
- 21 Jun 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to translate and culturally adapt Rivermead Extended Activities of Daily Life into the Urdu language and to evaluate its reliability and validity in the Pakistani neurological rehabilitation population. Also assess its correlation with Memory and Concentration Test, The Barthel Index, and The index of French activities.
Detailed description
As per the preceding commendation, Rivermead Extended Activities of Daily Life will be deciphered into the Urdu dialect from its English adaptation and adjusted socially in Pakistan. Among the neurological rehabilitation population, Rivermead Extended Activities of Daily Life will be distributed in 100 patients enrolled by comfort inspecting strategy beneath the pre-defined incorporation and avoidance criteria after marking assent shapes. For testing inter-observer unwavering quality and intra-observer unwavering quality of Rivermead Extended Activities of Daily Life, Memory and Concentration Test, index of French activities, and Barthel Index surveys will be managed by spectator, on the same day, with a time interval of 2 hours between 1st and 2nd readings. As for the 3rd readings, it will be carried out after seven days by the first observer, for intra-observer appraisal. Statistical Package of Social Sciences computer program has been utilized for information passage and examination. Inner consistency will be analyzed with Cronbach alpha esteem. Test-retest unwavering quality will be surveyed by utilizing an intra-class relationship coefficient. The Rivermead Extended Activities of Daily Life will be assessed for content validity, construct validity, criterion validity, and responsiveness.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- We targeted the Pakistani stroke and head injury population received rehabilitation for neurological impairments in our study.
Key inclusion criteria (3 listed)
- Patients from Rehabilitation centers mainly outpatients; with more or severe impairments due to neurological /neuro-muscular diseases.
- Patient should be in a stable state unlikely to change over 2- weeks.
- Patient should score 18/28 short orientation-memory-concentration test; indicating a reasonable cognitive and communicative ability.
Key exclusion criteria (2 listed)
- People not suffering from any neurological impairment.
- Scorning less than 18/28 on short orientation-memory-concentration test.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Rivermead Extended Activities of Daily Life
Time frame: 1st day
Rivermead Extended Activities of Daily Life having 10 things in it is in fact could be a complete independent community survival scale, covering all the fundamental independent living fashion needs. Restoration administrations are pointed at accomplishing social autonomy within the community, on the off chance that conceivable, and must utilize an fitting degree of Rivermead Extended Activities of Daily Life when they are assessed themselves.
Memory and Concentration Test
Time frame: 1st day
The Brief Introduction Memory and Concentration Test is one of numerous tests of memory and concentration. It has the advantage of having decently culture-free substance. In expansion, it covers moderately restricted zones of cognition: is the individual arranged; can the individual center on a brief errand; and can the person learn and keep in mind a number of basic things.
Frenchay Activities Index
Time frame: 1st day
The Frenchay Activities Index is a measure of instrumental activities of daily living for use with patients recovering from stroke.
Barthel Index
Time frame: 1st day
The Barthel index is used to assess disability and to monitor changes in disability over time. The scoring method takes into account whether the person evaluated receives help while doing each task.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jun 2022.
- Individual participant dataSharing planned: No
Related trials for Neurological Disorder
RecruitingObservational study
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Frontotemporal Dementia, Amyotrophic Lateral Sclerosis
RecruitingPhase 4
ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
Spinal Muscular Atrophy
Recruiting
Dry Needling in Multiple Sclerosis
Multiple Sclerosis
Not yet recruitingPhase 3
Efficacy and Safety of Minocycline Add-on in Patients With Neurosyphilis
Neurosyphilis
RecruitingPhase 1/2
000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
Brain Tumor, Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Muhammad Kashif study chair
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Neurological Disorder, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 21 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Muhammad Kashif (+92418777210, kashif.shaffi@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rivermead Extended Activities of Daily Life (time frame: 1st day). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jun 2022.